Eratos Therapeutics
PrivateLast Round
Accelerator
Feb 9, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Eratos Therapeutics operates in Healthcare & Life Sciences and is based in Portola Valley, California. Its latest recorded funding round was an Accelerator round in February 2026.
Eratos Therapeutics is a drug discovery company leveraging generative AI to identify new targets and develop CNS therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Mental Health
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eratos Therapeutics Comparables
Compare Eratos Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exin Therapeutics | 86% | |
| Forecast Bio, Inc. | 84% | |
| Bexorg | 80% |
For institutional investors. Book with your work email.
Eratos Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 9, 2026
Completed an Accelerator round of funding.
For institutional investors. Book with your work email.
Eratos Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Eratos Therapeutics's valuation, stock price, and market status.
Is Eratos Therapeutics a public or private company?
Eratos Therapeutics is a private company.
What is the current stock price of Eratos Therapeutics?
Eratos Therapeutics is a private company, so its shares have no public market price. Caplight tracks Eratos Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Eratos Therapeutics worth (valuation)?
Valuation information for Eratos Therapeutics is not publicly available.
Can I buy Eratos Therapeutics stock?
Eratos Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Eratos Therapeutics's last funding round?
Eratos Therapeutics's most recent funding round was Accelerator on February 9, 2026.
Who are the main investors in Eratos Therapeutics?
Investor information for Eratos Therapeutics is not publicly disclosed.
Will Eratos Therapeutics IPO soon?
No public IPO plans have been announced for Eratos Therapeutics.
How can I track Eratos Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Eratos Therapeutics's shares on secondary markets.